News

Dan Ma, PhD, joined the departments of Neurosurgery and Biomedical Engineering on Jan. 1, 2025. She is a scientist who focuses on the development and clinical translation of novel MRI technology to improve the understanding, diagnosis, and treatment of diseases.

New work from the Fecci Lab may explain why immunotherapies fail in the treatment of brain tumors.

Reflecting on the past year at Duke Neurosurgery, I am filled with gratitude for the achievements and milestones reached this year. It’s been a year of innovation, dedication, and progress, marking significant advancements in patient care, research, and community impact.

Laura Alder, MD, and Trey Mullikin, MD have been named deputy division directors of the Duke Center for Brain and Spine Metastasis (DCBSM).

An anonymous donor has made a $50 million gift to Duke University Health System toward the development of a proton beam therapy center.

Duke Regional Hospital, part of the Duke University Health System, was named the top acute care hospital in the United States by the Lown Institute, an independent think tank.

Jordan Komisarow, MD, assistant professor, has been named Vice Chair for Clinical Operations in the Department of Neurosurgery. In this pivotal leadership position, Dr. Komisarow oversees all aspects of clinical operations, driving the delivery of high-quality, patient-centered care while ensuring operational efficiency, compliance, and innovation.

Building on research that has linked immune responses with certain neurobehavioral conditions, researchers at Duke Health have identified how a key infection-fighting function is involved in triggering hyperactive behaviors in mice.

Nandan Lad, MD, PhD, has been inducted into the American Academy of Neurological Surgery, a prestigious honor conferred during the

Muhammad Abd-El-Barr MD, PhD, has been promoted to the rank of professor in the Duke Department of Neurosurgery.